Compare COR & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COR | AU |
|---|---|---|
| Founded | 2001 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.9B | 49.5B |
| IPO Year | 2001 | 2023 |
| Metric | COR | AU |
|---|---|---|
| Price | $331.41 | $109.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $390.62 | $119.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | 0.77% | ★ 3.94% |
| EPS Growth | ★ 5.71 | N/A |
| EPS | ★ 15.21 | N/A |
| Revenue | ★ $321,332,819,000.00 | N/A |
| Revenue This Year | $8.89 | $38.71 |
| Revenue Next Year | $6.75 | $2.89 |
| P/E Ratio | ★ $22.12 | $23.93 |
| Revenue Growth | ★ 9.31 | N/A |
| 52 Week Low | $244.82 | $62.55 |
| 52 Week High | $377.54 | $129.14 |
| Indicator | COR | AU |
|---|---|---|
| Relative Strength Index (RSI) | 65.64 | 59.34 |
| Support Level | $331.73 | $76.14 |
| Resistance Level | $350.77 | $113.70 |
| Average True Range (ATR) | 6.19 | 4.08 |
| MACD | 1.01 | -1.06 |
| Stochastic Oscillator | 91.90 | 53.36 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Anglogold Ashanti PLC is an independent gold mining company. It has a diversified asset portfolio, including production from operations in eight countries (Argentina, Australia, Brazil, Egypt, Ghana, Guinea, the DRC, and Tanzania), supported by greenfield projects in the United States and Colombia. The company's main product is gold, which once mined, is processed into dore (unrefined gold bars) on site and then dispatched to precious metals refineries. Geographically, Anglogold generates maximum revenue from its operations in Africa (comprising operations at Kibali, Iduapriem, Obuasi, Siguiri, Geita, and Sukari mines), followed by Australia (including Sunrise Dam and Tropicana), and the Americas (comprising Cerro Vanguardia, AngloGold Ashanti Mineracao, and Serra Grande operations).